CINECA IRIS Institutional Research Information System

RIBALDONE, Davide Giuseppe
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.587
EU - Europa 8.451
AS - Asia 6.130
SA - Sud America 988
AF - Africa 310
OC - Oceania 235
Continente sconosciuto - Info sul continente non disponibili 20
Totale 32.721
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.017
IT - Italia 2.743
CN - Cina 2.100
SG - Singapore 1.114
IE - Irlanda 827
DE - Germania 608
SE - Svezia 602
GB - Regno Unito 548
FR - Francia 494
ES - Italia 475
BR - Brasile 454
TR - Turchia 428
ID - Indonesia 398
JP - Giappone 393
IN - India 392
VN - Vietnam 382
PL - Polonia 329
CA - Canada 279
UA - Ucraina 248
MX - Messico 237
FI - Finlandia 210
AU - Australia 199
NL - Olanda 176
HK - Hong Kong 167
KR - Corea 165
CO - Colombia 164
AT - Austria 160
RU - Federazione Russa 142
BE - Belgio 123
EG - Egitto 121
CH - Svizzera 114
CL - Cile 114
TW - Taiwan 112
IR - Iran 109
PT - Portogallo 98
RO - Romania 97
PE - Perù 95
GR - Grecia 92
AR - Argentina 88
CZ - Repubblica Ceca 66
HU - Ungheria 62
DK - Danimarca 60
TH - Thailandia 57
IL - Israele 53
PK - Pakistan 44
SA - Arabia Saudita 42
NZ - Nuova Zelanda 35
EC - Ecuador 33
TN - Tunisia 32
PH - Filippine 31
HR - Croazia 29
MY - Malesia 23
NO - Norvegia 23
LT - Lituania 22
NG - Nigeria 21
IQ - Iraq 20
KE - Kenya 20
MA - Marocco 19
SI - Slovenia 19
VE - Venezuela 19
ZA - Sudafrica 19
ET - Etiopia 16
EU - Europa 16
PA - Panama 16
BG - Bulgaria 15
AE - Emirati Arabi Uniti 14
BD - Bangladesh 13
GH - Ghana 13
RS - Serbia 13
UY - Uruguay 13
CR - Costa Rica 12
EE - Estonia 12
DZ - Algeria 11
JO - Giordania 10
SN - Senegal 10
UZ - Uzbekistan 10
GT - Guatemala 9
SK - Slovacchia (Repubblica Slovacca) 9
LB - Libano 8
BA - Bosnia-Erzegovina 7
KW - Kuwait 7
KZ - Kazakistan 7
LV - Lettonia 6
AF - Afghanistan, Repubblica islamica di 5
BO - Bolivia 5
BY - Bielorussia 5
AL - Albania 4
AP - ???statistics.table.value.countryCode.AP??? 4
CU - Cuba 4
DO - Repubblica Dominicana 4
HN - Honduras 4
PS - Palestinian Territory 4
SD - Sudan 4
CI - Costa d'Avorio 3
GE - Georgia 3
KH - Cambogia 3
LU - Lussemburgo 3
LY - Libia 3
MO - Macao, regione amministrativa speciale della Cina 3
NP - Nepal 3
Totale 32.674
Salva come PNG Salva come JPEG
Città #
Ann Arbor 2.874
Chandler 1.532
Santa Clara 1.116
Fairfield 1.072
Singapore 910
Dublin 809
Ashburn 721
Beijing 610
Redwood City 565
Houston 533
Torino 524
Woodbridge 444
Seattle 403
Wilmington 398
Jacksonville 394
Cambridge 346
Turin 316
Columbus 266
Jakarta 245
Nyköping 241
Dong Ket 237
Princeton 212
Medford 209
Pisa 201
Milan 188
Villeurbanne 172
Shanghai 151
Warsaw 150
Dearborn 145
Guangzhou 130
Rome 120
Nanjing 119
Istanbul 112
Vienna 112
Boston 104
Hangzhou 96
San Diego 95
New York 90
London 86
Helsinki 85
Tokyo 85
Santiago 72
Seoul 71
Bogotá 67
Madrid 63
Lima 61
Barcelona 60
São Paulo 59
Brussels 57
Lappeenranta 57
Duncan 56
Ottawa 56
Wuhan 54
Hong Kong 52
Washington 52
Cairo 51
Chengdu 51
Toronto 50
Berlin 48
Los Angeles 48
Boardman 47
Fremont 46
Ankara 45
Upper Marlboro 45
Medellín 44
Zhengzhou 43
Bologna 42
Frankfurt am Main 42
Paris 41
Norwalk 40
Chicago 38
Taipei 38
Bengaluru 37
Amsterdam 36
Buenos Aires 36
Hyderabad 36
Naples 36
Athens 35
Hebei 35
Munich 34
Izmir 32
Hefei 30
Bangkok 29
Central District 29
Jinan 29
Tehran 29
Central 28
Moscow 26
San Francisco 26
Silver Spring 26
Prague 25
Sydney 25
Tainan City 25
Nuremberg 24
Rochester 24
Brisbane 23
Budapest 23
Chongqing 23
Hanoi 23
Melbourne 23
Totale 19.621
Salva come PNG Salva come JPEG
Nome #
Serum zonulin in patients with inflammatory bowel disease: a pilot study 1.824
Proctitis: a glance beyond inflammatory bowel diseases 1.101
Risk of drug interactions and prescription appropriateness in elderly patients 1.084
Glucose breath test and Crohn's disease: Diagnosis of small intestinal bacterial overgrowth and evaluation of therapeutic response 642
Inflammatory Cutaneous Lesions in Inflammatory Bowel Disease Treated With Vedolizumab or Ustekinumab: An ECCO CONFER Multicentre Case Series 630
Eosinophilic colitis: clinical review and 2020 update 610
The gut and the Inflammatory Bowel Diseases inside-out: the extra-intestinal manifestations 538
A randomized, double-blind, placebo-controlled pilot study to evaluate the efficacy and tolerability of a novel oral bioadhesive formulation for the treatment of nonerosive reflux disease-related symptoms 476
ACG Clinical Guideline on Crohn’s Disease: A Point of View from Europe 427
Management of Helicobacter pylori in Piedmont, Italy 352
The adherence to the therapy in inflammatory bowel disease: beyond the number of the tablets 348
Effectiveness and safety of adalimumab biosimilar ABP 501 in Crohn's disease: an observational study 314
Fecal calprotectin: beyond intestinal organic diseases 298
Significant improvement of glycemic control in diabetic patients with HCV infection responding to direct-acting antiviral agents 289
Differential diagnosis of pancreatic cysts: A prospective study on the role of intra-cystic glucose concentration 282
Adalimumab trough levels predict Crohn's disease clinical course 278
Risk factors of suspected spondyloarthritis among inflammatory bowel disease patients 274
Performance of protein induced by vitamin K absence or antagonist-II assessed by chemiluminescence enzyme immunoassay for hepatocellular carcinoma detection: a meta-analysis 273
Circulating Zonulin is Related to Hepatic Necroinflammation in Patients with Non Alcoholic Fatty Liver Disease 268
Gut microbiota and chronic exercise in diabetic patients: not only bacteria 251
Severe ulcerative colitis: predictors of response and algorithm proposal for rescue therapy 245
Biosimilar CT-P13 in treating ulcerative colitis in the real world 241
Primary Hypogammaglobulinaemia with Inflammatory Bowel Disease-Like Features: An ECCO CONFER Multicentre Case Series 236
Vedolizumab for treatment of chronic refractory pouchitis: a systematic review with pool analysis 234
Risk of incident melanoma in patients with inflammatory disease treated with anti-TNF: the Turin experience 230
Predictors of risk of fracture in inflammatory bowel diseases: a prospective study using FRAX score 221
Physiopathology of intestinal barrier and the role of zonulin 216
Helicobacter pylori infection and ischemic heart disease: could experimental data lead to clinical studies? 213
The therapy of chronic pouchitis 209
Prevalence of infectious agents in patients with systemic sclerosis: Defining the control group 204
Adalimumab versus azathioprine to halt the progression of bowel damage in Crohn’s disease: application of Lémann Index 202
Management of Pt1 tumours removed by endoscopy during colorectal cancer screening: Outcome and treatment quality indicators 201
Bone mineral density at diagnosis of celiac disease and after 1 year of gluten-free diet 197
Prevalence of Micronutrient Deficiency in Patients with Morbid Obesity Before Bariatric Surgery: What About Celiac Disease? 193
Food supplements, stress and gastrointestinal diseases 192
Inflammatory bowel disease course in liver transplant versus non-liver transplant patients for primary sclerosing cholangitis: LIVIBD, an IG-IBD study 188
Dupilumab to target interleukin 4 for inflammatory bowel disease? Hypothesis based on a translational message 186
Is there a link between periampullary diverticula and biliopancreatic disease? An EUS approach to answer the question 182
AMOXYCILLIN AND METRONIDAZOLE THERAPY FOR HELICOBACTER PYLORI ERADICATION: A 10-YEAR TREND IN TURIN, ITALY 177
Pediatric epilepsy and psychiatric comorbidity: could celiac disease diagnosis improve the outcome? 173
2013 update on celiac disease and eosinophilic esophagitis 170
Bariatric Surgery and Inflammatory Bowel Disease: a Role for Microbiota? 170
Adnexal localization of crohn’s disease and recurrent massive ovary cysts 167
Microscopic colitis in patients with mild duodenal damage: A new clinical and pathological entity ("lymphocytic enterocolitis")? 166
Analytical and clinical evaluation of a novel assay for anti-HBc IgG measurement in serum of subjects with overt and occult HBV infection 165
Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of care 161
Gastric emptying and related symptoms in patients treated with buspirone, amitriptyline or clebopride: a "real world" study by 13C-octanoic acid breath test 155
Modulation of the gut microbiota: opportunities and regulatory aspects 154
Comment on "Advanced Hepatic Fibrosis in Fatty Liver Disease Linked to Hyperplastic Colonic Polyp" 154
Apparent diffusion coefficient and enhancement patterns in MR imaging as markers of severe or moderate ileum inflammation in Crohn's disease 154
Does Helicobacter pylori infection increase the risk of adult-onset asthma? 152
Periodontal health and coronary heart disease: a comment 152
Clinical Response and Changes of Cytokines and Zonulin Levels in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome Treated with Bifidobacterium Longum ES1 for 8 or 12 Weeks: A Preliminary Report 152
Comments on Sulimani et al.: A weekly 35,000 IU vitamin D supplementation improves bone turnover markers in vitamin D deficient Saudi adolescent females 151
Targeting IL-10, ZO-1 gene expression and IL-6/STAT-3 trans-signalling by a combination of atorvastatin and mesalazine to enhance anti-inflammatory effects and attenuate progression of oxazolone-induced colitis 150
On Inverse Association between Helicobacter pylori Gastritis and Microscopic Colitis: The European Data 149
Diagnosis of Helicobacter pylori infection: a look into molecular aspects of urea breath test 149
How ameliorate the adherence in patients with inflammatory bowel disease? 146
OC. 12.4 PRIMARY SCLEROSING CHOLANGITIS ASSOCIATED WITH INFLAMMATORY BOWEL DISEASE: ANALYSIS OF INTESTINAL OUTCOME AFTER LIVER TRANSPLANTATION 145
V.02.10 AN INNOVATIVE EVALUATION OF PANCREATIC CYSTS BY CONFOCAL LASER ENDOMICROSCOPY AND FIBER OPTIC LIGHTING DIRECT VISUALIZATION SYSTEM 144
Helicobacter pyloriinfection and asthma: Is there a direct or an inverse association? A meta-analysis 144
Endoscopic ultrasound to diagnose pneumatosis cystoides intestinalis (with video) 144
Helicobacter pylori and proton pump inhibitor therapy: One diagnostic method is enough? 144
Outcomes of COVID-19 in 79 patients with IBD in Italy: An IG-IBD study 143
Power Doppler sonography to predict the risk of surgical recurrence of Crohn’s disease 142
Comment on Helicobacter pylori seroprevalence and the occurrence and severity of psoriasis 142
Efficacy of infliximab biosimilars in patients with Crohn's disease 141
Real time visualization may be advisable to exclude aspiration in patients undergoing capsule endoscopy examination 140
Is Helicobacter pylori the infectious trigger for headache?: A review 139
Mo1920 – Results of Interim Analysis of a Retrospective Igibd Study on Adalimumab Use in Real Practice in Italy: the Real-Life Clinical Effectiveness of Adalimumab in Ulcerative Colitis (REALADA-UC) Study 138
Correlation between Thiopurine S-Methyltransferase Genotype and Adverse Events in Inflammatory Bowel Disease Patients 138
Response to: Comment on "efficacy of 7-Day and 14-Day Triple Therapy Regimens for the Eradication of Helicobacter pylori: A Comparative Study in a Cohort of Romanian Patients" 137
Use of probiotics in the Helicobacter pylori eradication in Italy: data from the Italian Registry on Helicobacter pylori treatment 137
Dual biological therapy with anti-TNF, vedolizumab or ustekinumab in inflammatory bowel disease: a systematic review with pool analysis 136
Inflammation in gastrointestinal disorders: prevalent socioeconomic factors 134
Adalimumab Therapy Improves Intestinal Dysbiosis in Crohn's Disease 134
Helicobacter pylori eradication: poor medical compliance from East to West of the world 133
A Concise History of Thiopurines for Inflammatory Bowel Disease: From Anecdotal Reporting to Treat-to-Target Algorithms 133
A 2016 panorama of Helicobacter pylori infection: key messages for clinicians 132
Features of inflammatory bowel disease followed in a second level center in Northern Italy 132
P02.38 | Current practice of Gastroenterologists in the treatment of Helicobacter pylori infection in Italy: data from the Italian Registry on H. pylori treatment 131
Mo1867 ITALIAN REAL-LIFE STUDY EVALUATING THE LONG TERM EFFECTIVENESS OF VEDOLIZUMAB FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE 130
Association Between Gut Permeability and Insulin Resistance: Any Role for Zonulin in Patients with Non-Alcoholic Fatty Liver Disease? 130
Oral Manifestations of Inflammatory Bowel Disease and the Role of Non-Invasive Surrogate Markers of Disease Activity 129
How to interpret meta-analysis results 128
Role of bowel ultrasound as a predictor of surgical recurrence of Crohn's disease 128
Higher Efficiency of Percutaneous Microwave (MWA) Than Radiofrequency Ablation (RFA) in Achieving Complete Response in Cirrhotic Patients with Early Hepatocellular Carcinoma 127
AISF position paper on HCV in immunocompromised patients 126
Laboratory evidence of Helicobacter species infection in hepatocellular carcinoma 124
Rifabutin-Based Rescue Therapy for Helicobacter pylori Eradication: A Long-Term Prospective Study in a Large Cohort of Difficult-to-Treat Patients 123
Biomarkers of oncogenesis, adipose tissue dysfunction and systemic inflammation for the detection of hepatocellular carcinoma in patients with nonalcoholic fatty liver disease 122
Benefit of supplements in functional dyspepsia after treatment of Helicobacter pylori 121
On-Treatment Decrease of Serum Interleukin-6 as a Predictor of Clinical Response to Biologic Therapy in Patients with Inflammatory Bowel Diseases 121
IS THERE A LINK BETWEEN PERIAMPULLARY DIVERTICULA AND BILIOPANCREATIC DISEASES? AN EUS APPROACH TO ANSWER THE QUESTION 120
Comment on "Factors Associated with Recurrent Ulcers in Patients with Gastric Surgery after More Than 15 Years: A Cross-Sectional Single-Center Study" 120
THE ROLE OF ANTI-IFI16 ANTIBODIES IN THE MANAGEMENT OF INFLAMMATORY BOWEL DISEASES (IBD) 119
Osteoporosis, osteopenia, and inflammatory bowel disease: lessons from a real‑world study 119
Helicobacter pylori prevalence: Are the data totally reliable? 118
Prognostic Role of Serum Cytokeratin-19 Fragment (CYFRA 21-1) in Patients with Hepatocellular Carcinoma 118
Sa1825 ITALIAN REAL-LIFE STUDY EVALUATING THE LONG-TERM EFFECTIVENESS OF VEDOLIZUMAB FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE: THE ELDERLY COHORT 117
Totale 23.039
Salva come PNG Salva come JPEG
Categoria #
all - tutte 91.807
article - articoli 0
book - libri 0
conference - conferenze 5.954
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 97.761
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.564 0 0 0 0 0 268 308 423 462 422 276 405
2020/20214.931 275 435 407 346 379 455 364 300 405 441 408 716
2021/20227.212 377 297 317 374 319 367 1.364 1.170 915 371 699 642
2022/20236.378 499 457 319 518 620 1.131 599 464 738 296 429 308
2023/20244.695 440 504 294 384 463 495 283 467 87 342 398 538
2024/20254.539 265 473 592 756 1.828 625 0 0 0 0 0 0
Totale 33.801